The True Minimally Invasive Way to Treat BPH | Expert Panel Session

The last decade has seen a significant shift and growth in the surgical
options available in the management of symptomatic BPH. Not least
driven by patients keen to take up options that avoid a general
anaesthetic, that are truly ambulatory, allowing a more rapid return to
normal activities but also that avoid the risk of significant post-operative
complications, including the development of permanent dry ejaculation
and/ or impotence. iTind fulfils all these patient desires and now with
randomised and long-term data, as well as FDA approval, an expert panel
will examine this device, its mechanism of action, reflect upon the body of
high-quality data available and discuss the role of iTIND in the surgical
armamentarium in 2023.
00:00:00 Welcome & Introduction - Dr. Neil Barber (UK)
00:04:22 Which role plays the appropriate patient selection in the
outcome of BPH treatment with iTind? - Dr. Silvia Secco (Italy)
00:13:02 iTind procedure using a flexible cystoscope: technique,
advantages, limitations, my personal experience - Dr. Bilal
Chughtai (USA)
00:20:53 iTind procedure using a rigid cystoscope: technique,
advantages, limitations, my personal experience - Dr. Luca
Cindolo (Italy)
00:39:58 The best site of care for iTind: office vs OR - Dr. Bilal Chughtai
(USA), Dr. Neil Barber (UK)
00:52:16 BPH symptoms relief from a patient's point of view
00:57:59 Clinical evidence on iTind - Dr. Bilal Chughtai (USA)
01:04:39 Training pathway - lessons learned and recommendations -
Dr. Silvia Secco (Italy)
01:15:56 Panel discussion and closing remarks - All faculty moderated by
Dr. Neil Barber (UK)
Faculty:
Dr. Neil Barber - FRCS(Urol), Consultant Urological and Robotic
Surgeon, Lead for Urology, Director Frimley Benign Prostate Clinical
Research Centre, Director Frimley Renal Cancer Centre, Frimley Health
NHS Foundation Trust, Frimley Park Hospital, UK
Dr. Silvia Secco - MD, Urology Consultant - ASST Grande Ospedale
Metropolitano Niguarda, Italy
Dr. Bilal Chughtai - MD, Associate Professor of Urology, Weill Cornell
Medical Center, USA
Dr. Luca Cindolo - MD, PhD, FEBU, Consultant Urologist, Villa Stuart
Private Hospital, Co-Founder of CUrE, Italy